12.3
Regime posologico: dosi orali multiple
Comprendere l’andamento nel tempo della concentrazione di un farmaco nell’organismo è un aspetto cruciale della farmacocinetica, soprattutto in presen…
I livelli di farmaco nell'organismo dopo dosi orali multiple seguono uno schema ripetuto di picchi e minimi, che riflettono le fasi di assorbimento ed eliminazione.
Nel tempo, questo modello si stabilizza, formando un ritmo costante di livelli massimi e minimi, noto come stato stazionario.
La concentrazione media allo stato stazionario rappresenta l'equilibrio tra l'assorbimento e la clearance del farmaco.
La clearance influenza direttamente il livello medio di stato stazionario: una clearance più bassa si traduce in una concentrazione media più elevata.
La previsione dei livelli massimi e minimi di farmaco aiuta a regolare gli intervalli di dosaggio per ottenere un beneficio terapeutico ottimale.
Dopo una singola dose, il picco di concentrazione plasmatica e il momento in cui si verifica sono fattori cruciali nelle decisioni di dosaggio.
I farmaci con un indice terapeutico ristretto possono causare pericolose fluttuazioni dei livelli plasmatici dei farmaci.
Dosi più piccole e più frequenti aiutano a ridurre al minimo queste fluttuazioni, mantenendo la stessa concentrazione media e garantendo picchi e minimi più sicuri e più bassi.
Per molti farmaci potenti, l'intervallo di somministrazione è spesso guidato dall'emivita di eliminazione. Tuttavia, per farmaci come il warfarin, il dosaggio è guidato da parametri di monitoraggio terapeutico.
View the full transcript and gain access to JoVE Core videos
Q1: What is the sawtooth pattern in multiple oral dosage regimens?
The sawtooth pattern represents periodic peaks and troughs in plasma drug concentration that occur with each dose administration and subsequent elimination. After multiple doses, this pattern stabilizes into a consistent rhythm known as steady state, where the rate of drug absorption equals the rate of elimination, creating a predictable equilibrium between maximum and minimum drug levels.
Q2: How does clearance affect steady-state drug concentration?
Clearance inversely impacts the mean plasma level at steady state. Lower clearance results in higher average drug concentration, while higher clearance produces lower concentrations. This relationship is fundamental to dosing decisions, as clinicians must adjust doses based on individual clearance rates to maintain therapeutic drug levels without causing toxicity or subtherapeutic effects.
Q3: Why are smaller, more frequent doses used for drugs with narrow therapeutic indices?
Drugs with narrow therapeutic indices can cause dangerous fluctuations in plasma drug levels. Smaller, more frequent doses minimize these fluctuations by maintaining the same average concentration while ensuring safer, lower peaks and troughs. This dosing strategy reduces toxicity risk while preserving therapeutic efficacy and maintaining consistent drug exposure.
Q4: What factors determine maximum and minimum drug concentrations in multiple dosing?
Maximum and minimum drug concentrations depend on dose size, clearance, dosing interval, bioavailability, volume of distribution, and the elimination rate constant. These parameters are incorporated into equations that calculate Cmax and Cmin values. Understanding determination of multiple dosing parameters steady state minimum and maximum concentrations helps optimize regimens for therapeutic efficacy while minimizing toxicity.
Q5: How does the elimination half-life guide dosing intervals?
For many potent drugs, the dosing interval is often guided by the elimination half-life, which determines how quickly the body removes the drug. However, some drugs like warfarin require dosing guided by therapeutic monitoring parameters rather than half-life alone. This individualized approach ensures drugs maintain therapeutic levels while accounting for patient-specific factors affecting drug clearance and response.
Q6: What is the significance of peak plasma concentration timing in dosage decisions?
After a single dose, the peak plasma concentration and the time it occurs are crucial factors in dosage decisions. These parameters help predict maximum drug levels and determine optimal dosing intervals. Calculating the time to reach maximum concentration and peak concentration after each dose provides essential details for designing effective dosing schedules that maintain therapeutic efficacy while minimizing toxicity.
Q7: How do bioavailability and volume of distribution affect multiple-dose plasma concentrations?
Bioavailability and volume of distribution are key parameters affecting plasma concentration at any time during a multiple-dose regimen. Bioavailability determines the fraction of administered dose reaching systemic circulation, while volume of distribution reflects drug distribution throughout body tissues. Together with dose, dosing interval, and elimination rate constant, these factors determine whether drug levels remain within the therapeutic window.